CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Short Interest Update

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the recipient of a significant increase in short interest during the month of February. As of February 28th, there was short interest totalling 36,700 shares, an increase of 184.5% from the February 13th total of 12,900 shares. Based on an average daily trading volume, of 117,300 shares, the days-to-cover ratio is currently 0.3 days.

CERo Therapeutics Price Performance

NASDAQ CEROW traded up $0.00 during trading hours on Friday, hitting $0.01. The company’s stock had a trading volume of 6,740 shares, compared to its average volume of 106,276. The company’s 50 day simple moving average is $0.01 and its two-hundred day simple moving average is $0.01. CERo Therapeutics has a 12 month low of $0.00 and a 12 month high of $0.13.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.